期刊
CHEMMEDCHEM
卷 16, 期 15, 页码 2354-2365出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.202100122
关键词
antibacterial agents; antifungal agents; imidazole; MTT assay; thiadiazole
资金
- National Natural Science Foundation of China [82060623]
- Edanz Group China
Three series of new imidazole-fused imidazo[2,1-b][1,3,4]thiadiazole analogues have been synthesized and evaluated for their antibacterial and antifungal activities. One of the compounds showed strong antifungal activity with high selectivity for Candida albicans. This compound exhibited significantly higher activity against C. albicans compared to the positive control compounds.
Three series of new imidazole-fused imidazo[2,1-b][1,3,4]thiadiazole analogues (compounds 20 a-g, 21 a-g, and 22 a-g) have been synthesized, and their antibacterial and antifungal activities have been evaluated. All the target compounds showed strong antifungal activity and high selectivity for the test fungus Candida albicans over Gram-positive and -negative bacteria. N-((4-(2-Cyclopropyl-6-(4-fluorophenyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl)-5-(6-methyl-pyridin-2-yl)-1H-imidazol-2-yl)methyl)aniline (21 a) showed the highest activity against C. albicans (MIC50=0.16 mu g/mL), 13 and three times that of the positive control compounds gatifloxacin and fluconazole, respectively. Compounds 21 a and 20 e did not show cytotoxicity against human foreskin fibroblast-1 cells, and compound 21 a was as safe as the positive control compounds in hemolysis tests. These results strongly suggest that some of the compounds produced in this work have value for development as antifungal agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据